ReviewJournal of global health2019
Forty years since Alma-Ata: do we need a new model for noncommunicable diseases?
Review in Journal of global health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity?Lipids in health and disease · 2025Article
- Functional dependency level and later-life incident multimorbidity in older people: longitudinal evidence from 19 countries in China and Europe.BMC public health · 2025Article
- Pathways Linking ICT Use to Chronic Disease Self-Management Among Older Adults with Comorbidities in Shanghai, China.Healthcare (Basel, Switzerland) · 2025Article
- The Longitudinal Relationship Between Allostatic Load and Multimorbidity Among Older Americans.Geriatrics (Basel, Switzerland) · 2025Article
- Strategies to address non-communicable diseases in the Commonwealth of Independent States countries: a scoping review.Primary health care research & development · 2022Article
- Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania.Diabetic medicine : a journal of the British Diabetic Association · 2022Article
- Multimorbidity.Nature reviews. Disease primers · 2022Review
- Health system responses for type 1 diabetes: A scoping review.Diabetic medicine : a journal of the British Diabetic Association · 2022Article
- Burden of treatment as a measure of healthcare quality: An innovative approach to addressing global inequities in multimorbidity.PLOS global public health · 2022Article
- Forty years after Alma-Ata: primary health-care preparedness for chronic diseases in Mozambique, Nepal and Peru.Global health action · 2021Article
- Comorbid depression in medical diseases.Nature reviews. Disease primers · 2020Review
- Report of the WHO independent high-level commission on NCDs: where is the focus on addressing inequalities?BMJ global health · 2020Article
- Multimorbidity and acute infectious diseases in urban and semi-urban settings in Peru: A mixed-methods study.Journal of multimorbidity and comorbidityArticle
- Multimorbidity matters in low and middle-income countries.Journal of multimorbidity and comorbidityReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.